Zymeworks Inc. Common Stock Capital Reinvestment Ratio
Zymeworks Inc. Common Stock capital reinvestment ratio. Zymeworks Inc. Common Stock (ZYME) has a Capital Reinvestment Ratio of 0.07x as of June 2025, meaning it reinvests 0% of its operating cash flow ($12.07 Million) in capital expenditures ($884.00K). Check ZYME cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Zymeworks Inc. Common Stock (2017–2022)
Capital reinvestment ratio of Zymeworks Inc. Common Stock from 2017 to 2022. This chart tracks Zymeworks Inc. Common Stock's Capital Reinvestment Ratio across 3 annual periods. Also explore net asset momentum of Zymeworks Inc. Common Stock to track the company's year-over-year net asset growth rate.
Zymeworks Inc. Common Stock Capital Reinvestment Ratio by Year (2017–2022)
Zymeworks Inc. Common Stock capital reinvestment ratio by year from 2017 to 2022. For the full cash flow conversion analysis, see ZYME cash flow conversion.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2022 | 0.09x | $144.11 Million | $13.12 Million | ▼ -35.6% |
| 2018 | 0.14x | $24.18 Million | $3.42 Million | ▼ -99.0% |
| 2017 | 14.25x | $219.00K | $3.12 Million | — |